The U.S. Food and Drug Administration (FDA) has granted an emergency use authorization (EUA) to Applied DNA for its Linea COVID-19 assay kit.
The authorization expands the kit's intended use to include serial screening of asymptomatic individuals and eliminates the need for a prescription.
